Contribution: Industrial Research Assistance Program – Contributions to Firms
Artron BioResearch Inc.
$463,864.00
COVID-19 Response - Rapid SARS-CoV-2 IgM/IgG Antibody Test with Smartphone Application Software Support and Centralized Data Transfer
FY 2020-21 · 2020-05-18
Summary
The project is to develop a Lateral Flow Immuno-Assay (LFIA) based COVID-19 IgM/IgG test to detect SARS-CoV-2 IgM and IgG antibody in the blood samples with overall sensitivity>94%, specificity>97%. This device is designed for both professional and/or home-use by serum,plasma as well as fingertip blood sample test.
This diagnostic solution will integrate with a mobile application, QR code and cloud network. The innovation will allow for real-time monitoring of COVID-19 spread by transmitting timely data to the public health networks; hence, achieving a low-cost and high-efficiency solution for the the relevant Public Health Agency for effective collection of test data.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Burnaby|Burnaby, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
859367245
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-05-18 | 2020-21 | $463,864.00 |
| 1 | 2020-05-18 | 2020-21 | $463,864.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 90 jours.
Agreement End Date
2021-03-31
Agreement Number
950321
Agreement Start Date
2020-05-18
Agreement Title
COVID-19 Response - Rapid SARS-CoV-2 IgM/IgG Antibody Test with Smartphone Application Software Support and Centralized Data Transfer
Agreement Title (French)
Réponse à la COVID-19 - Test rapide de détection des anticorps IgM/IgG du SRAS-CoV-2 avec prise en charge du logiciel d'application pour smartphone et transfert centralisé des données
Agreement Type
Contribution
Agreement Value
$463,864.00
Amendment Date
2020-09-29
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project is to develop a Lateral Flow Immuno-Assay (LFIA) based COVID-19 IgM/IgG test to detect SARS-CoV-2 IgM and IgG antibody in the blood samples with overall sensitivity>94%, specificity>97%. This device is designed for both professional and/or home-use by serum,plasma as well as fingertip blood sample test.
This diagnostic solution will integrate with a mobile application, QR code and cloud network. The innovation will allow for real-time monitoring of COVID-19 spread by transmitting timely data to the public health networks; hence, achieving a low-cost and high-efficiency solution for the the relevant Public Health Agency for effective collection of test data.
Description (French)
Le projet consiste à mettre au point un test immunologique à flux latéral basé sur le test de la COVID-19 IgM/IgG pour détecter les anticorps IgM et IgG du SRAS-CoV-2 dans les échantillons de sang avec une sensibilité globale de > 94 % et une une spécificité de > 97 %. Ce dispositif est conçu pour une utilisation professionnelle ou domestique par le test de sérum, de plasma et d'échantillons de sang prélevés au bout du doigt. Cette solution de diagnostic s'intégrera à une application mobile, un code QR et un réseau en nuage. L'innovation permettra de surveiller en temps réel la propagation de la COVID-19 en transmettant des données en temps utile aux réseaux de santé publique; ce qui permettra à l'Agence de santé publique compétente de disposer d'une solution peu coûteuse et très efficace pour la collecte efficace des données du test.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burnaby South
Federal Riding (French)
Burnaby-Sud
Federal Riding Number
59003
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
859367245
Recipient City
Burnaby|Burnaby
Recipient Country
CA
Recipient Legal Name
Artron BioResearch Inc.
Recipient Operating Name
Artron
Recipient Postal Code
V5J 5H6
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q1-950321
